Personal tools

Coexpression cluster:C424: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C424_Hepatocyte_liver_Synoviocyte_tenocyte_Fibroblast_Adipocyte_Cardiac |id=C424 }}")
 
No edit summary
Line 1: Line 1:
{{Coexpression_clusters
{{Coexpression_clusters
|full_id=C424_Hepatocyte_liver_Synoviocyte_tenocyte_Fibroblast_Adipocyte_Cardiac
|full_id=C424_Hepatocyte_liver_Synoviocyte_tenocyte_Fibroblast_Adipocyte_Cardiac
|gostat_on_coexpression_clusters=GO:0006508!proteolysis!0.0132525917284209!715;51279;710$GO:0004252!serine-type endopeptidase activity!0.0132525917284209!715;51279$GO:0008236!serine-type peptidase activity!0.0132525917284209!715;51279$GO:0017171!serine hydrolase activity!0.0132525917284209!715;51279$GO:0004175!endopeptidase activity!0.033273032044513!715;51279$GO:0006958!complement activation, classical pathway!0.033273032044513!710$GO:0002455!humoral immune response mediated by circulating immunoglobulin!0.033273032044513!710$GO:0006956!complement activation!0.033273032044513!710$GO:0002541!activation of plasma proteins during acute inflammatory response!0.033273032044513!710$GO:0016064!immunoglobulin mediated immune response!0.033273032044513!710$GO:0019724!B cell mediated immunity!0.033273032044513!710$GO:0008233!peptidase activity!0.033273032044513!715;51279$GO:0002253!activation of immune response!0.033273032044513!710$GO:0002449!lymphocyte mediated immunity!0.033273032044513!710$GO:0006959!humoral immune response!0.033273032044513!710$GO:0002460!adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains!0.033273032044513!710$GO:0002250!adaptive immune response!0.033273032044513!710$GO:0002443!leukocyte mediated immunity!0.033273032044513!710$GO:0002526!acute inflammatory response!0.033273032044513!710$GO:0050778!positive regulation of immune response!0.033273032044513!710$GO:0002684!positive regulation of immune system process!0.033273032044513!710$GO:0050776!regulation of immune response!0.033273032044513!710$GO:0007596!blood coagulation!0.033273032044513!710$GO:0002682!regulation of immune system process!0.033273032044513!710$GO:0050817!coagulation!0.033273032044513!710$GO:0007599!hemostasis!0.033273032044513!710$GO:0051240!positive regulation of multicellular organismal process!0.033273032044513!710$GO:0002252!immune effector process!0.033605128731863!710$GO:0045087!innate immune response!0.0336202558677497!710$GO:0050878!regulation of body fluid levels!0.0355140395553653!710$GO:0042060!wound healing!0.0355140395553653!710$GO:0044267!cellular protein metabolic process!0.0355140395553653!715;51279;710$GO:0044260!cellular macromolecule metabolic process!0.0357225886968076!715;51279;710$GO:0019538!protein metabolic process!0.0379340249739084!715;51279;710$GO:0008015!blood circulation!0.0379340249739084!710$GO:0003013!circulatory system process!0.0379340249739084!710$GO:0004867!serine-type endopeptidase inhibitor activity!0.0387405217571341!710
|id=C424
|id=C424
}}
}}

Revision as of 17:40, 18 May 2012


Full id: C424_Hepatocyte_liver_Synoviocyte_tenocyte_Fibroblast_Adipocyte_Cardiac



Phase1 CAGE Peaks

Hg19::chr11:57367575..57367593,+p7@SERPING1
Hg19::chr12:7167997..7168040,+p1@C1S
Hg19::chr12:7168041..7168058,+p2@C1S
Hg19::chr12:7169832..7169844,+p8@C1S
Hg19::chr12:7169889..7169902,+p6@C1S
Hg19::chr12:7169907..7169929,+p5@C1S
Hg19::chr12:7170214..7170228,+p9@C1S
Hg19::chr12:7170229..7170249,+p10@C1S
Hg19::chr12:7171627..7171662,+p4@C1S
Hg19::chr12:7175756..7175804,+p@chr12:7175756..7175804
+
Hg19::chr12:7177634..7177646,+p@chr12:7177634..7177646
+
Hg19::chr12:7177786..7177801,+p@chr12:7177786..7177801
+
Hg19::chr12:7177864..7177876,+p@chr12:7177864..7177876
+
Hg19::chr12:7187896..7187912,-p@chr12:7187896..7187912
-
Hg19::chr12:7241517..7241547,-p@chr12:7241517..7241547
-
Hg19::chr12:7241961..7241984,-p@chr12:7241961..7241984
-
Hg19::chr12:7242235..7242247,-p@chr12:7242235..7242247
-
Hg19::chr12:7242281..7242299,-p@chr12:7242281..7242299
-
Hg19::chr12:7242779..7242821,-p9@C1R
Hg19::chr12:7244160..7244201,-p6@C1R
Hg19::chr12:7244222..7244240,-p8@C1R
Hg19::chr12:7244261..7244276,-p12@C1R
Hg19::chr12:7245018..7245073,-p1@C1R
Hg19::chr12:7261772..7261874,-p1@C1RL


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0006508proteolysis0.0132525917284209
GO:0004252serine-type endopeptidase activity0.0132525917284209
GO:0008236serine-type peptidase activity0.0132525917284209
GO:0017171serine hydrolase activity0.0132525917284209
GO:0004175endopeptidase activity0.033273032044513
GO:0006958complement activation, classical pathway0.033273032044513
GO:0002455humoral immune response mediated by circulating immunoglobulin0.033273032044513
GO:0006956complement activation0.033273032044513
GO:0002541activation of plasma proteins during acute inflammatory response0.033273032044513
GO:0016064immunoglobulin mediated immune response0.033273032044513
GO:0019724B cell mediated immunity0.033273032044513
GO:0008233peptidase activity0.033273032044513
GO:0002253activation of immune response0.033273032044513
GO:0002449lymphocyte mediated immunity0.033273032044513
GO:0006959humoral immune response0.033273032044513
GO:0002460adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains0.033273032044513
GO:0002250adaptive immune response0.033273032044513
GO:0002443leukocyte mediated immunity0.033273032044513
GO:0002526acute inflammatory response0.033273032044513
GO:0050778positive regulation of immune response0.033273032044513
GO:0002684positive regulation of immune system process0.033273032044513
GO:0050776regulation of immune response0.033273032044513
GO:0007596blood coagulation0.033273032044513
GO:0002682regulation of immune system process0.033273032044513
GO:0050817coagulation0.033273032044513
GO:0007599hemostasis0.033273032044513
GO:0051240positive regulation of multicellular organismal process0.033273032044513
GO:0002252immune effector process0.033605128731863
GO:0045087innate immune response0.0336202558677497
GO:0050878regulation of body fluid levels0.0355140395553653
GO:0042060wound healing0.0355140395553653
GO:0044267cellular protein metabolic process0.0355140395553653
GO:0044260cellular macromolecule metabolic process0.0357225886968076
GO:0019538protein metabolic process0.0379340249739084
GO:0008015blood circulation0.0379340249739084
GO:0003013circulatory system process0.0379340249739084
GO:0004867serine-type endopeptidase inhibitor activity0.0387405217571341



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

This analysis result is provided for C0 - C305 clusters.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C424&oldid=1703190"